
Experience
Chimerix Announces Acquisition by Jazz Pharmaceuticals for $935 Million
March 5, 2025
Cooley advised Chimerix (Nasdaq: CMRX), a biopharmaceutical company with a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, on its definitive agreement to be acquired by Jazz Pharmaceuticals (Nasdaq: JAZZ) for $8.55 per share in cash – totaling approximately $935 million.
Related contacts
Related Practices & Industries
LegalZoom Announces Acquisition of Formation Nation
February 10, 2025
Cooley advised LegalZoom (Nasdaq: LZ), an online platform for legal services, on its acquisition of Formation Nation, a small-business services company.
Related contacts
Related Practices & Industries
H1 Acquires Ribbon Health
January 8, 2025
Cooley advised H1, a global healthcare data technology company, on its acquisition of Ribbon Health.
Related contacts
Related Practices & Industries
Brigit Announces up to $460 Million Sale to Upbound Group
December 12, 2024
Cooley advised Brigit, a financial health technology company, on its definitive agreement to be acquired by Upbound Group (Nasdaq: UPBD), a technology- and data-driven leader in accessible and inclusive financial products that address the evolving needs and aspirations of underserved consumers, for total consideration of up to $460 million.
Related contacts
Related Practices & Industries
Hootsuite to Acquire Talkwalker
April 8, 2024
Cooley advised Hootsuite, a global leader in social media management, on its definitive agreement to acquire Talkwalker, a top artificial intelligence-powered social listening solution.
Related contacts
Related Practices & Industries
Related news and events
Admissions and credentials
New York